Brain CancerFeaturedNeurology·October 9, 2017·4 min readCombination Treatment Targeting Glucose in Advanced Brain Cancer Shows Promising Results in Preclinical StudyUCLA researchers report erlotinib, an FDA approved drug, reduces glucose uptake in glioblastoma, effectively cutting off nutrients and energy supply to the tumor.Read More
